Skip to main content

Table 2 The situation of ovarian stimulation in the two groups

From: The effect of flexible low-dose GnRH antagonist on pregnancy outcome in the fresh embryo transfer cycle of IVF-ET: a randomized controlled trial

 

Test group

Control group

p

(n = 101)

(n = 110)

E2 on start day on Cetrotide (pg/ml)

371.00 ± 322.42

378.94 ± 351.71

0.865

LH on start day on Cetrotide (IU/L)

2.59 ± 2.00

2.95 ± 2.83

0.294

P on start day on Cetrotide (nmol/l)

1.01 ± 0.44

1.03 ± 0.40

0.691

E2 on HCG day (pg/ml)

2840.17 ± 1505.21

2629.78 ± 1580.56

0.324

LH on HCG day (IU/L)

3.93 ± 3.77

3.57 ± 3.13

0.452

P on HCG day(nmol/l)

2.81 ± 1.17

2.85 ± 1.03

0.777

Endometrial thickness on HCG day (mm)

11.26 ± 2.01

11.35 ± 2.28

0.779

Total dosage of Cetrotide (mg)

1.13 ± 0.41

1.61 ± 0.59

 < 0.001

The day of Cetrotide (days)

6.75 ± 2.11

6.61 ± 2.29

0.638

Total dosage of Gn(IU)

1892.08 ± 475.08

1945.00 ± 507.80

0.436

The day of Gn(days)

10.31 ± 2.19

10.57 ± 2.35

0.398

Number of oocytes retrieved

12.93 ± 7.04

12.06 ± 6.54

0.355

Number of fertilized oocytes

9.71 ± 5.58

8.88 ± 4.98

0.254

Number of embryos

9.40 ± 5.55

8.75 ± 4.97

0.370

Number of available embryos

7.45 ± 4.82

6.93 ± 4.31

0.411

Number of high-quality embryos

3.89 ± 3.16

4.15 ± 2.91

0.543

Premature LH rise

18.81% (19/101)

15.45% (17/110)

0.584